tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Noxopharm Initiates First SOF-SKN™ Dose in HERACLES Trial
PremiumCompany AnnouncementsNoxopharm Initiates First SOF-SKN™ Dose in HERACLES Trial
2M ago
Noxopharm Advances HERACLES Clinical Trial for Autoimmune Drug
Premium
Company Announcements
Noxopharm Advances HERACLES Clinical Trial for Autoimmune Drug
3M ago
Noxopharm’s Sofra Platform Shows Promising Results in BioRay Collaboration
Premium
Company Announcements
Noxopharm’s Sofra Platform Shows Promising Results in BioRay Collaboration
3M ago
Noxopharm Unveils Promising SOF-SKN Data at Rheumatology Conference
PremiumCompany AnnouncementsNoxopharm Unveils Promising SOF-SKN Data at Rheumatology Conference
4M ago
Noxopharm Advances SOF-SKN™ to First Human Trials in Australia
Premium
Company Announcements
Noxopharm Advances SOF-SKN™ to First Human Trials in Australia
4M ago
Noxopharm Advances Drug Development with Key Agreements and Preclinical Success
Premium
Company Announcements
Noxopharm Advances Drug Development with Key Agreements and Preclinical Success
4M ago
Noxopharm’s SOF-SKN™ Passes Key Safety Tests Ahead of Clinical Trials
PremiumCompany AnnouncementsNoxopharm’s SOF-SKN™ Passes Key Safety Tests Ahead of Clinical Trials
7M ago
Noxopharm Ltd. Issues Convertible Notes to Enhance Capital Structure
Premium
Company Announcements
Noxopharm Ltd. Issues Convertible Notes to Enhance Capital Structure
8M ago
Noxopharm Issues New Unquoted Equity Securities
Premium
Company Announcements
Noxopharm Issues New Unquoted Equity Securities
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100